- Home
- Books
- An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy
- Chapter
Epidemiology of COVID-19
- Authors: Dharmendra Kumar Khatri1, Anitha Sriram2, Yojana Bhor3, Srushti Mahajan4, Rahul Kumar5, Saurabh Srivastava6, Shashi Bala Singh7, Pankaj Kumar Singh8
-
View Affiliations Hide AffiliationsAffiliations: 1 Department of Biological Sciences, National Institute of Pharmaceutical Education andResearch (NIPER), Hyderabad, India 2 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research(NIPER), Hyderabad, India 3 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research(NIPER), Hyderabad, India 4 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research(NIPER), Hyderabad, India 5 Department of Biological Sciences, National Institute of Pharmaceutical Education andResearch (NIPER), Hyderabad, India 6 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research(NIPER), Hyderabad, India 7 Department of Biological Sciences, National Institute of Pharmaceutical Education andResearch (NIPER), Hyderabad, India 8 Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research(NIPER), Hyderabad, India
- Source: An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy , pp 67-90
- Publication Date: August 2022
- Language: English
Epidemiology of COVID-19, Page 1 of 1
< Previous page | Next page > /docserver/preview/fulltext/9789815039863/chap4-1.gifThe epidemiology of COVID-19 infection will be understood by the relationship between the intensity of action on public well-being and the rate of its transmission control. The virus is a chemical substance that is vulnerable until it invades the living body. The molecular assembly of the virus contains RNA genome and proteins. When 2019-nCoV enters the host cell of the living body, it continues its progeny by the replication process. It starts to make molecular assemblies for every new virion produced through replication and transcription. Though the incubation time is accounted for to range between 1 to 14 days, the median incubation period is 5 days. According to a recent survey on COVID-19 patients, 80 percent of patients are asymptomatic. This book chapter describes the life cycle and spread of 2019-nCoV, CFR, clinical manifestations, diagnosis, and prevention of COVID-19. nbsp;
-
From This Site
/content/books/9789815039863.chap4dcterms_subject,pub_keyword-contentType:Journal105